Results 1 to 10 of about 13,757,225 (358)

Hepatitis B Vaccines [PDF]

The Journal of Infectious Diseases, 2021
Hepatitis B is caused by the hepatitis B virus (HBV), which infects the liver and may lead to chronic liver disease, including cirrhosis and hepatocellular carcinoma. HBV represents a worldwide public health problem, causing major morbidity and mortality.
J. Pattyn, Greet Hendrickx, A. Vorsters, P. van Damme   +3 more
semanticscholar   +5 more sources

Health-related quality of life for adults living with hepatitis B in the United States: a qualitative assessment

Journal of Patient-Reported Outcomes, 2021
Background In 2019, an estimated 296 million people were living with chronic hepatitis B virus (HBV) globally with approximately 2.4 million living within the United States.
Catherine Freeland, Rhea Racho, Maureen Kamischke, Kate Moraras, Evangeline Wang, Chari Cohen, Stuart Kendrick   +6 more
doaj   +1 more source

APASL clinical practice guideline on hepatitis B reactivation related to the use of immunosuppressive therapy

Hepatology International, 2021
Hepatitis B reactivation related to the use of immunosuppressive therapy remains a major cause of liver-related morbidity and mortality in hepatitis B endemic Asia-Pacific region.
G. Lau, Ming‐Lung Yu, G. Wong, A. Thompson, H. Ghazinian, J. Hou, T. Piratvisuth, J. Jia, M. Mizokami, G. Cheng, Guo-feng Chen, Zhen-wen Liu, O. Baatarkhuu, A. Cheng, W. Ng, Patrick Lau, T. Mok, Jer-Ming Chang, S. Hamid, A. Dokmeci, R. Gani, D. Payawal, P. Chow, Joong-Won Park, S. Strasser, R. Mohamed, K. Win, Tanwandee Tawesak, S. Sarin, M. Omata   +29 more
semanticscholar   +1 more source

Common concerns, barriers to care, and the lived experience of individuals with hepatitis B: a qualitative study

BMC Public Health, 2021
Background An estimated between 257 and 292 million people live with chronic HBV globally. While much is known about the causes, and epidemiology of HBV, little is understood about the quality of life and impact of HBV on those living with the infection.
Catherine Freeland, Sean Farrell, Priyanka Kumar, Maureen Kamischke, Michaela Jackson, Sierra Bodor, Timothy M. Block, Rosemary Frasso, Chari Cohen   +8 more
doaj   +1 more source

Alinity m, a Random-Access System, for Hepatitis B Virus DNA Quantification in Plasma and Whole Blood Collected on Dried Blood Spots

mSphere, 2022
The International Liver Association recommends the use of accurate and sensitive molecular methods for determination of hepatitis B virus (HBV) DNA levels in plasma or serum of chronic HBsAg carriers. The level of HBV replication represents the strongest
Valérie Ortonne, Quentin Lucas, Olivia Garrigou, Alexandre Soulier, Dominique Challine, Jean-Michel Pawlotsky, Vincent Leroy, Stéphane Chevaliez   +7 more
doaj   +1 more source

Update on prevention, diagnosis, and treatment of chronic hepatitis B: AASLD 2018 hepatitis B guidance

Hepatology, 2018
This AASLD 2018 Hepatitis B Guidance is intended to complement the AASLD 2016 Practice Guidelines for Treatment of Chronic Hepatitis B and update the previous hepatitis B virus (HBV) guidelines from 2009. The 2018 updated guidance on chronic hepatitis B (
N. Terrault, A. Lok, B. McMahon, Kyong‐Mi Chang, Jessica P. Hwang, M. Jonas, Robert S. Brown, N. Bzowej, J. Wong   +8 more
semanticscholar   +2 more sources

The unvirtuous cycle of discrimination affecting people with hepatitis B: a multi-country qualitative assessment of key-informant perspectives

International Journal for Equity in Health, 2022
Background An estimated 296 million individuals live with chronic hepatitis B worldwide, most have not been diagnosed and remain at risk of liver disease and cancer.
Catherine Freeland, Lindsay Mendola, Vivian Cheng, Chari Cohen, Jack Wallace   +4 more
doaj   +1 more source

A Novel Insertion in the Hepatitis B Virus Surface Protein Leading to Hyperglycosylation Causes Diagnostic and Immune Escape

Viruses, 2023
Chronic hepatitis B virus (HBV) infection is a global health threat. Mutations in the surface antigen of HBV (HBsAg) may alter its antigenicity, infectivity, and transmissibility.
Felix Lehmann, Heiko Slanina, Martin Roderfeld, Elke Roeb, Jonel Trebicka, John Ziebuhr, Wolfram H. Gerlich, Christian G. Schüttler, Bernhard Schlevogt, Dieter Glebe   +9 more
doaj   +1 more source

Hepatitis B Virus: Advances in Prevention, Diagnosis, and Therapy

Clinical Microbiology Reviews, 2020
Currently, despite the use of a preventive vaccine for several decades as well as the use of effective and well-tolerated viral suppressive medications since 1998, approximately 250 million people remain infected with the virus that causes hepatitis B ...
M. Nguyen, G. Wong, E. Gane, J. Kao, G. Dusheiko   +4 more
semanticscholar   +1 more source

Hepatitis B [PDF]

Nature Reviews Gastroenterology & Hepatology, 2018
na
Zoulim, Fabien, Levrero, Massimo, Testoni, Barbara   +2 more
openaire   +1 more source